Literature DB >> 19491886

Development of pouchitis with combination therapy with peg-interferon alpha-2b and ribavirin for chronic hepatitis C in a patient with ulcerative colitis who underwent pouch surgery.

Kenichi Morimoto, Hirokazu Yamagami, Shuhei Hosomi, Mizuki Ohira, Takehisa Suekane, Noriko Kamata, Mitsue Sogawa, Kenji Watanabe, Kazunari Tominaga, Toshio Watanabe, Yasuhiro Fujiwara, Akihiro Tamori, Nobuhide Oshitani, Tetsuo Arakawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19491886     DOI： 10.1038/ajg.2009.120

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  3 in total

1.  Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis.

Authors:  Jay Luther; Stephanie Y Owyang; Tomomi Takeuchi; Tyler S Cole; Min Zhang; Maochang Liu; John Erb-Downward; Joel H Rubenstein; Chun-Chia Chen; Anna V Pierzchala; Jose A Paul; John Y Kao
Journal:  Gut       Date:  2011-04-06       Impact factor: 23.059

2.  Successful sofosbuvir treatment with ribavirin dose reduction for chronic hepatitis C virus genotype 2 infection in a patient with ulcerative colitis: a case report.

Authors:  Yuki Ohta; Tatsuo Kanda; Tatsuro Katsuno; Shin Yasui; Yuki Haga; Reina Sasaki; Masato Nakamura; Shuang Wu; Shingo Nakamoto; Makoto Arai; Osamu Yokosuka
Journal:  BMC Gastroenterol       Date:  2016-07-11       Impact factor: 3.067

3.  Interferon-Induced Crohn's Disease: An Unusual Side Effect of Interferon Therapy in a Patient With Chronic Hepatitis C Virus Infection.

Authors:  Omer Basar; Francis Dailey; Erica Dailey; Veysel Tahan; Ebubekir Daglilar
Journal:  Cureus       Date:  2021-06-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.